Core Insights - The Progressive Corporation reported weaker-than-expected earnings for Q3, with earnings per share at $4.06, missing the consensus estimate of $5.04 [1] - Quarterly sales were reported at $20.849 billion, also falling short of the analyst consensus estimate of $21.819 billion [1] - Following the earnings announcement, Progressive shares declined by 2.2% to $221.57 [1] Analyst Ratings and Price Targets - B of A Securities analyst Joshua Shanker maintained a Buy rating and raised the price target from $350 to $351 [3] - Citigroup analyst Matthew Heimermann maintained a Buy rating but lowered the price target from $312 to $301.38 [3] - Wells Fargo analyst Elyse Greenspan maintained an Equal-Weight rating and reduced the price target from $266 to $246 [3] - BMO Capital analyst Michael Zaremski maintained a Market Perform rating and cut the price target from $252 to $247 [3] - Keefe, Bruyette & Woods analyst Meyer Shields maintained a Market Perform rating and lowered the price target from $270 to $262 [3]

Core Insights - Chewy Inc. reported better-than-expected earnings for Q1, with adjusted earnings of 35 cents per share, a 12.9% increase year-over-year, surpassing the consensus of 34 cents and management guidance of 30-35 cents [1] - The company achieved sales of $3.12 billion, reflecting an 8.3% year-over-year growth, exceeding the consensus of $3.08 billion and management guidance of $3.06 billion-$3.09 billion [1] Financial Outlook - For fiscal year 2025, Chewy anticipates sales between $12.30 billion and $12.45 billion, slightly below Wall Street's estimate of $12.54 billion [2] - The expected adjusted EBITDA margin for 2025 is projected to be between 5.4% and 5.7%, compared to 4.8% for fiscal year 2024 [2] - For Q2 2025, Chewy forecasts sales of $3.06 billion to $3.09 billion, above the consensus of $3.03 billion, and adjusted earnings of 30-35 cents per share versus a consensus of 31 cents [2] Stock Performance - Following the earnings announcement, Chewy shares increased by 2.5%, trading at $41.79 [3] Analyst Ratings and Price Targets - JP Morgan analyst Doug Anmuth maintained an Overweight rating and raised the price target from $36 to $47 [6] - Mizuho analyst David Bellinger maintained a Neutral rating and lowered the price target from $47 to $44 [6] - Wedbush analyst Scott Devitt maintained an Outperform rating and raised the price target from $39 to $45 [6] - Evercore ISI Group analyst Mark Mahaney maintained an Outperform rating and raised the price target from $47 to $52 [6] - Citigroup analyst Steven Zaccone maintained a Buy rating and raised the price target from $42 to $49 [6] - Guggenheim analyst Steven Forbes maintained a Buy rating and raised the price target from $42 to $45 [6]